• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Oct27
Hvsen Biotech released FY2025 Q3 earnings on October 27 After-Market BJT, actual revenue CNY 437.33 M, actual EPS CNY 0.3495
01:00
Hvsen Biotech released FY2025 9 Months earnings on October 27 After-Market (BJT), actual revenue CNY 1.26 B, actual EPS CNY 0.9854
01:00
Oct20
Hvsen Biotech to Release FY2025 Q3 Earnings on October 28 After-Market (BJT)
01:09
Aug12
Huisheng Biology Increases Investment in Pet Medicine R&D and Market Channels
01:27
Aug7
Huisheng Bio's Pet Drug Enconazole Has Obtained Production License and Launched
01:31
Aug5
Huisheng Biotech Subsidiary Invests in Veterinary Drug Production Line Upgrades
10:49

Schedules & Filings

Schedules
Filings
Oct27
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 437.33 M, Net Income 70.72 M, EPS 0.3495

Aug26
Distribution Plan(CST)

Cash dividend 0.1 CNY

Distribution Plan(CST)

Cash dividend 0.1 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy